Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli.

Literature DB >> 2426471

Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli.

N Tanese, J Sodroski, W A Haseltine, S P Goff.

Abstract

The pol gene from a biologically active clone of the human T-cell lymphotropic virus type III provirus was inserted into a bacterial expression vector. The resulting gene fusion induced the formation of active reverse transcriptase that could be readily detected in extracts of bacterial cells. The activity exhibited the template and divalent cation requirements of the authentic enzyme. These constructs will be useful for safe and rapid analysis of potential inhibitors of this important enzyme.

Entities: Species

Mesh：

Substances：

Year: 1986 PMID： 2426471 PMCID： PMC253253

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

17 in total

1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors: M M Bradford
Journal: Anal Biochem Date: 1976-05-07 Impact factor: 3.365

Review 2. Molecular approaches for designing antiviral and antitumor compounds.

Authors: P Chandra
Journal: Top Curr Chem Date: 1974

3. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors: S Goff; P Traktman; D Baltimore
Journal: J Virol Date: 1981-04 Impact factor: 5.103

4. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.

Authors: D G Kleid; D Yansura; B Small; D Dowbenko; D M Moore; M J Grubman; P D McKercher; D O Morgan; B H Robertson; H L Bachrach
Journal: Science Date: 1981-12-04 Impact factor: 47.728

Review 5. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors: A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal: Ann Intern Med Date: 1984-01 Impact factor: 25.391

6. Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors: K R Spindler; D S Rosser; A J Berk
Journal: J Virol Date: 1984-01 Impact factor: 5.103

7. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).

Authors: R C Gallo; P S Sarin; E P Gelmann; M Robert-Guroff; E Richardson; V S Kalyanaraman; D Mann; G D Sidhu; R E Stahl; S Zolla-Pazner; J Leibowitch; M Popovic
Journal: Science Date: 1983-05-20 Impact factor: 47.728

8. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors: F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal: Science Date: 1983-05-20 Impact factor: 47.728

9. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors: R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal: Science Date: 1984-05-04 Impact factor: 47.728

10. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus).

Authors: M A Rey; B Spire; D Dormont; F Barre-Sinoussi; L Montagnier; J C Chermann
Journal: Biochem Biophys Res Commun Date: 1984-05-31 Impact factor: 3.575

16 in total

1. Profile of Stephen P. Goff. Interview by Greg Williams.

Authors: Stephen P Goff
Journal: Proc Natl Acad Sci U S A Date: 2010-12-13 Impact factor: 11.205

2. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.

Authors: A J Smith; M I Cho; M L Hammarskjöld; D Rekosh
Journal: J Virol Date: 1990-06 Impact factor: 5.103

3. Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.

Authors: Y W Hu; C Y Kang
Journal: Proc Natl Acad Sci U S A Date: 1991-06-01 Impact factor: 11.205

4. Characterization of HIV-1 reverse transcriptase with antibodies indicates conformational differences between the RNAse H domains of p 66 and p 15.

Authors: A M Szilvay; S Nornes; A Kannapiran; B I Haukanes; C Endresen; D E Helland
Journal: Arch Virol Date: 1993 Impact factor: 2.574

5. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors: A Hizi; C McGill; S H Hughes
Journal: Proc Natl Acad Sci U S A Date: 1988-02 Impact factor: 11.205

6. A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity.

Authors: S F Le Grice; R Zehnle; J Mous
Journal: J Virol Date: 1988-07 Impact factor: 5.103

7. Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors: V R Prasad; S P Goff
Journal: Proc Natl Acad Sci U S A Date: 1989-05 Impact factor: 11.205